Metrics in pregnancy: is it the time for new glycaemic goals for pregnant women with type 1 diabetes? An experience with advanced hybrid closed loop
Acta Diabetologica · 2025
DOI: 10.1007/s00592-025-02590-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Diabetologica, 2025. Verfasst von O Bitterman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Diabetology Unit , San Paolo Hospital , ASL Roma 4, Civitavecchia, Italy. olimpia.bitterman@gmail.com. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Blood Glucose, Pregnancy in Diabetics, Glycemic Control. Die Arbeit nennt 25 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
INTRODUCTION: Recommended pregnancy specific Time in Range (TIR) 63-140 mg/dl is a quite wide range and, even if the goal of > 70% is achieved, the specific targets for fasting and mean glycaemia, which are much lower than 140 mg/dl, could not be complied. This case series aimed to explore the performance of an Advanced Hybrid closed Loop (AHCL) in pregnancy on a stricter glycaemic range. METHODS: We collected retrospective data about recommended glucose metrics and an hypothetic TITR 63-95 mg/dl, more suitable for fasting periods, from 11 type 1 diabetes patients, using Medtronic MiniMed™ 780G, with glucose target 100 mg/dl and Active Insulin Time 2 h, from preconceptional phase until delivery. RESULTS: TIR 63-140 mg/dl quickly improved throughout pregnancy, with progressively improving HbA1c and no significant changes in Time Below Range (TBR). TITR 63-95 mg/dl was 26% in the 1st trimester, 20% in the 2nd and 30% in the 3rd, corresponding to 6, 5 and 7 h per day, less than the hypothetic 8/24 hours of fasting. TAR > 140 reduced more compared to TAR > 95, reflecting a greater improve in postprandial values than in fasting. CONCLUSIONS: Although the AHCL Medtronic MiniMed™ 780G helped improving glycaemic control during pregnancy, our patients spent very few hours in the range 63-95 mg/dl, probably because they did not reach fasting glucose goals. A stricter TIR may be hypothesized for pregnant women too, as an additional goal along with TIR 63-140 mg/dl, but studies are needed to explore the consequences on maternal and fetal outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetology Unit , San Paolo Hospital , ASL Roma 4, Civitavecchia, Italy. olimpia.bitterman@gmail.com.
- Outpatient Clinic of Diabetology, District63, Asl Salerno, Italy.
- Israelitico Hospital , Rome, Italy.
- International Medical University Unicamillus , Rome, Italy.
- Cdc Santa Famiglia, Rome, Italy.
Zitieren
APA
Bitterman, O., Fresa, R., & Napoli, A. (2025). Metrics in pregnancy: is it the time for new glycaemic goals for pregnant women with type 1 diabetes? An experience with advanced hybrid closed loop. Acta Diabetologica. https://doi.org/10.1007/s00592-025-02590-4
Vancouver
Bitterman O, Fresa R, Napoli A. Metrics in pregnancy: is it the time for new glycaemic goals for pregnant women with type 1 diabetes? An experience with advanced hybrid closed loop. Acta Diabetologica. 2025. doi:10.1007/s00592-025-02590-4
BibTeX
@article{Bitterman2025,
author = {Bitterman, O and Fresa, R and Napoli, A},
title = {Metrics in pregnancy: is it the time for new glycaemic goals for pregnant women with type 1 diabetes? An experience with advanced hybrid closed loop},
journal = {Acta Diabetologica},
year = {2025},
doi = {10.1007/s00592-025-02590-4}
}
EUVIMED